These results suggest that PHMG-p-mediated activation of calpain-1 via the P2RX7/Ca2+ signaling pathway could induce pulmonary disease by impairing the barrier function of the bronchial epithelium (Figure 5). Here, CAPN1 is linked to lung disorder.